ST

STAA

$23.42
Sharia status
COMPLIANT
Per our secondary compliance provider · assessed 2026-08-25
HTR non-permissible income <0.01%

Methodology breakdown computing — it will appear here on its own.

🕌Open research, not a fatwa — verify with your own scholar.
Trade setup SEPARATE FROM SHARIAH
⚪ NEUTRAL — No Edge
Signals are mixed with no clear edge in either direction. Stand aside and wait for one more confluence factor.
37
of 100
Setup confidence — system conviction, not win probabilityD
Why this signal?
Structure2 of 5 timeframes bullish · 26.1% aligned
VWAPPrice below VWAP ($23.69)
VolumeRelative volume 4.8× the 20-day average
Momentum10-day rate of change +1.1%
Overall readNEUTRAL — No Edge

Staar Surgical Co. (STAA) is currently considered halal (Sharia-compliant), per our secondary compliance provider (last assessed 2026-08-25). See the full ratio breakdown and business-activity screen below for the reasoning.

Market & analysts
Wall Street consensus
HOLD
18 analysts
Price target
$27.90
+19.1% · 10 analysts
Institutional own.
111.6% *
of shares
Momentum (10d)
+1.1%
rate of change
SMC grade
D · 37
26.1% aligned
COMPLIANT
Sharia compliance
<0.01%
Non-permissible income — HTR, from filings (2026-01-02)
D · 37
SMC grade — 26.1% timeframe alignment
+1.1%
Rate of change (10d)
HOLD
Wall Street consensus (18)
$27.90
Price target (+19.1%) · 10 analysts
111.6%
Institutional ownership *

🕌 In-house Compliance Research

Computing the full ratio and business-activity breakdown for STAA — this runs off the critical path so the page paints first. It will appear here on its own.

33.3429.0324.7220.4116.102025-09-112026-03-122026-09-10

Pinch or scroll to zoom · drag to pan — both axes move · double-click to reset

Support & Resistance
S3
22.34
S2
22.85
S1
23.24
PIVOT
23.75
R1
24.14
R2
24.65
R3
25.04

Classic floor-trader pivots from the last completed daily bar. Highlighted pills are the levels bracketing the current price.

Price Forecast

7-day expected range
20.3357 25.8843
±12.0% from 23.11, made 2026-09-03 · resolves 2026-09-10
STRONG SELL
from 19 indicators
Not enough resolved predictions yet — 0 of 10 needed before we publish an accuracy figure. 21806 forecast(s) are currently open and will be scored automatically when their horizon expires.

The range is measured volatility (ATR over the horizon), not a target — a wider band means a more volatile asset, not a stronger view. The direction is the indicator tally above. Every forecast is recorded when made and scored against the real price when it comes due, including the wrong ones. Not a recommendation, and not a fatwa.

Technical Summary

STRONG SELL
19 indicators
OscillatorsSTRONG BUY
3 buy · 4 neutral · 0 sell
Moving averagesSTRONG SELL
1 buy · 0 neutral · 11 sell
Every indicator, and what it reads
IndicatorValueSignal
RSI (14)46.60NEUTRAL
Stochastic %K (14)63.46NEUTRAL
CCI (20)-20.25NEUTRAL
Williams %R (14)-36.54NEUTRAL
MACD (12,26,9)0.16BUY
ROC (10)2.45BUY
Momentum (10)0.56BUY
EMA (10)23.46SELL
SMA (10)23.20BUY
EMA (20)23.64SELL
SMA (20)23.62SELL
EMA (30)23.99SELL
SMA (30)23.84SELL
EMA (50)24.63SELL
SMA (50)24.76SELL
EMA (100)25.13SELL
SMA (100)26.82SELL
EMA (200)24.52SELL
SMA (200)24.00SELL

Standard indicator thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20, MACD histogram sign, price vs. average) computed on daily bars. A summary of what common indicators say — not a recommendation, and not this site's own trading verdict.

About Staar Surgical Co.

Healthcare · Medical Instruments & Supplies

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, and sells phakic implantable lenses for the eye and accessory delivery systems to deliver the lenses into the eye. The company offers implantable collamer lens product family (ICLs) comprising EVO ICL, EVO+ ICL, EVO Visian ICL, and EVO Viva ICL for use in refractive surgery for the treatment of visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It serves health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as ophthalmologists. The company sells its products directly through its sales representatives in Japan, the United States, Germany, Spain, Singapore, Canada, and the United Kingdom, as well as through representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.

staar.com ↗

Background via Yahoo Finance — informational, not part of the verdict.

Verdict

⚪ NEUTRAL — No Edge

Signals are mixed with no clear edge in either direction. Stand aside and wait for one more confluence factor.

Scores: 2 bullish / 2 bearish

Grade verdict

Weak — low conviction, small size or skip

SMC — Top Down

TimeframeBiasBars
📅 Daily RANGING 62
⏰ 4H RANGING 38
🕐 1H BULLISH 98
⏱ 15-Min BULLISH 130
⏲ 5-Min BEARISH 234

Momentum & Volume

-0.41
MACD (no fresh cross)

Peer Movement

Peer movement computing — it will appear here on its own.

Insider Activity (90d)

NEUTRAL   0 buys · 0 sells

COT Positioning — E-MINI S&P 500 - CHICAGO MERCANTILE EXCHANGE

NEUTRAL   report date 2026-09-01 · Asset managers net 934180 (-19048)

AI Summary

Plain-language summary of the evidence already on this page — the Sharia screen, structure, momentum, and order flow above. It explains the read; it doesn't make the call. Generated on demand (a live AI call), never run automatically.

Tell us what's working, what's confusing, or what you want to see next — read by a real person, not a form that goes nowhere.